Suicide, Attempted: Clinical Trials

5 trials for Suicide, Attempted, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Suicide, Attempted: new trials by email Literature Review of Suicide, Attempted trials Research Report on Suicide, Attempted

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
Ketamine Hydrochloride, Midazolam Hydrochloride - Suicide, Attempted, Suicide and Depression
Phase 3CompletedUniversity of Texas Southwestern Medical Center502022-10-032026-10-15
Short Message System (SMS) Monitoring Intended for the Suicidal Patients
SMS contact with patient after discharge in intervention group - Patients Having Realized a Suicide Attempt
Phase 3CompletedUniversity Hospital, Brest5302014-08-202025-01-23
RCT of Post-Suicide Attempt Case Management (ACTION-J)
Case management, Enhanced usual care - Suicide Attempt
Phase 3CompletedJapan Foundation for Neuroscience and Mental Health9142006-06-012014-01-16
Treatment of Adolescent Suicide Attempters (TASA)
fluoxetine, sertraline, citalopram - Depression, Suicide, Attempted
Phase 2 / Phase 3CompletedNew York State Psychiatric Institute1202004-03-012020-06-22
Community-Based Cognitive Therapy for Suicide Attempters
CBT, Standard care alone - Suicide, Attempted
Phase 3CompletedUniversity of Pennsylvania1402004-02-012014-06-10

Narrower conditions

Depression (2)  ·  Dysthymic Disorder (1)  ·  Recurrence (1)  ·  Suicidal Ideation (1)  ·  Suicide (1)

Broader conditions

Behavior (5)  ·  Behavioral Symptoms (5)  ·  Self-Injurious Behavior (5)  ·  Suicide (4)  ·  Depressive Disorder (1)  ·  Disease Attributes (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Bupropion (1)  ·  Case Management (1)  ·  Citalopram (1)  ·  Cognitive Behavioral Therapy (1)  ·  Escitalopram (1)  ·  Fluoxetine (1)  ·  Ketamine (1)  ·  Lithium (1)  ·  Midazolam (1)  ·  Mirtazapine (1)  ·  Sertraline (1)  ·  Venlafaxine Hydrochloride (1)

Sponsors

Japan Foundation for Neuroscience and Mental Health (1)  ·  New York State Psychiatric Institute (1)  ·  University Hospital, Brest (1)  ·  University of Pennsylvania (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (3)  ·  France (1)  ·  Japan (1)

Top investigators

Laurence Greenhill, MD (1)  ·  Madhukar Trivedi, MD (1)  ·  Yoshio Hirayasu, MD,PhD (1)

Results publications

PMID 33884617, PMID 19730273, PMID 19730274, PMID 25404215, PMID 26360731, PMID 29321126, PMID 32368793, PMID 34332432, PMID 42849709

NIH funding

R01MH067805 (1), R01MH125181 (1), U10MH066750 (1), U10MH066762 (1), U10MH066769 (1), U10MH066775 (1), U10MH066778 (1)